Oncology Institute (TOIIW) Short term Debt (2020 - 2021)

Oncology Institute (TOIIW) posted Short term Debt of $183000.0 for Q4 2021, down 96.59% quarter-over-quarter from $5.4 million in Q4 2020, and down 96.59% year-on-year from $5.4 million in Q4 2020.

Oncology Institute (TOIIW) Short term Debt (2020 - 2021) Analysis & Trends

Oncology Institute (TOIIW) has reported Short term Debt for 2 consecutive years, with $183000.0 the latest figure, recorded in Q4 2021.

  • Short term Debt for Q4 2021 came in at $183000.0, down 96.59% year-over-year; the trailing twelve-month figure through Dec 2021 was $183000.0 (down 96.59% YoY), and the FY2021 annual result was $183000.0, down 96.59% from the prior year.
  • Short term Debt was $183000.0 for Q4 2021 at Oncology Institute, down from $5.4 million in the prior quarter.
  • Over five years, Short term Debt peaked at $5.4 million in Q4 2020 and troughed at $183000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 Oncology Institute - - 139.16 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 183,000.00
Dec 31, 2020 5.37 Mn